Analysis of influencing factors and interaction of body weight and disease outcome in patients with prediabetes

Table 7 Analysis of the interaction between body weight and independent influencing factors

Independent variable	β	SE	Wals	P value	OR	95%CI
Weight	2.664	0.52	26.23	< 0.001	14.356	5.179-39.795
Glycosylated hemoglobin	2.772	0.606	20.948	< 0.001	15.987	4.878-52.390
Weight by glycosylated hemoglobin	-0.828	0.82	1.021	0.312	0.437	0.088-2.178
Constant	-3.082	0.457	45.408	< 0.001	0.046	-
Weight	2.453	0.565	18.86	< 0.001	11.625	3.842-35.174
Uric acid	1.887	0.578	10.664	0.001	6.6	2.127-20.484
Weight by uric acid	1.953	0.719	1.758	0.005	0.386	0.094-1.577
Constant	-2.923	0.459	40.545	0	0.054	-
Weight	2.883	0.565	26.066	< 0.001	17.86	5.906-54.009
FINS	2.578	0.622	17.189	< 0.001	13.174	3.894-44.570
Weight by FINS	-0.797	0.833	0.916	0.339	0.451	0.088-2.305
Constant	-3.229	0.51	40.113	< 0.001	0.04	-
Weight	3.31	1.08	9.39	0.002	27.375	3.296-227.343
HOMA-IR	3.067	1.049	8.55	0.003	21.471	2.749-167.718
Weight by HOMA-IR	-1.463	1.15	1.619	0.203	0.231	0.024-2.205
Constant	-4.29	1.007	18.159	< 0.001	0.014	-

FINS: Fasting insulin; HOMA-IR: Homeostatic model assessment for insulin resistance; OR: Odds ratio; CI: Confidence interval.